The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVN.L Regulatory News (AVN)

  • There is currently no data for AVN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Feb 2012 10:13

RNS Number : 1630Y
Avanti Communications Group Plc
27 February 2012
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Avanti Communications Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Caledonia Investments plc

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23 February 2012

6. Date on which issuer notified:

24 February 2012

7. Threshold(s) that is/are crossed orreached: vi, vii

15% and 14%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1p

12,922,000

12,922,000

15,347,000

15,347,000

0

13.73%

0

GB00B1VCNQ84

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

 

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

15,347,000

13.73%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

Percentage of voting rights based on total voting rights announced on 24 February 2012

14. Contact name:

G P Denison, Company Secretary

15. Contact telephone number:

+44 20 7802 8080

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEAXAFAAEFF
Date   Source Headline
26th Feb 20159:04 amRNSHolding(s) in Company
26th Feb 20157:01 amRNSHolding(s) in Company
23rd Feb 20153:22 pmRNSResult of General Meeting
5th Feb 20157:00 amRNSCapital Raising
5th Feb 20157:00 amRNSInterim Results
13th Jan 20158:00 amRNSNotice of Results
27th Nov 20143:26 pmRNSResult of AGM
27th Nov 20147:11 amRNSDirectorate Change
13th Nov 20147:00 amRNSQ1 Trading Update
4th Nov 20144:00 pmRNSAnnual Financial Report
17th Oct 20147:00 amRNSIssue of Equity
13th Oct 20148:37 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSFinal Results
12th Sep 20147:00 amRNSContract Win
11th Aug 20147:00 amRNSHylas 4 Contracts Complete
5th Aug 20147:00 amRNSContract Win
18th Jul 20147:00 amRNSTrading Statement
7th Jul 20149:24 amRNSDirector/PDMR Shareholding
7th Jul 20149:21 amRNSDirector/PDMR Shareholding
7th Jul 20147:00 amRNSContract win
4th Jul 20149:28 amRNSDirector/PDMR Shareholding
4th Jul 20149:28 amRNSDirector/PDMR Shareholding
4th Jul 20148:50 amRNSDirector/PDMR Shareholding
4th Jul 20147:00 amRNSContract Win
2nd Jul 20141:21 pmRNSHolding(s) in Company
13th Jun 20143:03 pmRNSAnnouncement
13th Jun 20147:00 amRNSBond Proceeds
3rd Jun 20142:00 pmRNSContract Win and Financing Update
29th May 20147:00 amRNSContract Win
20th May 20147:00 amRNSRe Contract Win
16th May 201411:57 amRNSDirector/PDMR Shareholding
15th May 20147:00 amRNSHolding(s) in Company
13th May 20147:00 amRNSContract Win
12th May 20147:00 amRNSQ3 Trading Update
2nd May 20147:00 amRNSContract Win
30th Apr 20147:00 amRNSContract Win
19th Feb 20147:00 amRNSContract win with Vodafone
12th Feb 20147:00 amRNSInterim Results
15th Jan 20147:00 amRNSInterim results date and US dollar reporting
16th Dec 20137:00 amRNSContract win of ESA Satellite
14th Nov 201311:36 amRNSResult of AGM
14th Nov 20137:00 amRNSDirectorate Change
25th Oct 20134:36 pmRNSChange of AGM Venue
30th Sep 20138:16 amRNSDirector/PDMR Shareholding
27th Sep 20137:00 amRNSAvanti raises $370m bond
20th Sep 20138:46 amRNSDirector/PDMR Shareholding
11th Sep 20139:42 amRNSDirector/PDMR Shareholding
11th Sep 20137:00 amRNSDirector/PDMR Shareholding
10th Sep 20134:35 pmRNSPrice Monitoring Extension
10th Sep 20139:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.